BiOptic Inc. (6850.TWO)
- Previous Close
46.00 - Open
46.50 - Bid --
- Ask --
- Day's Range
45.60 - 47.40 - 52 Week Range
38.20 - 63.00 - Volume
53,656 - Avg. Volume
24,510 - Market Cap (intraday)
1.414B - Beta (5Y Monthly) --
- PE Ratio (TTM)
62.67 - EPS (TTM)
0.75 - Earnings Date --
- Forward Dividend & Yield 0.20 (0.43%)
- Ex-Dividend Date Aug 21, 2024
- 1y Target Est
--
BiOptic Inc., a biotechnology instrumentation company, develops scientific products for research and clinical applications. It offers instruments, such as bio-fragment analyzers and PCR thermocyclers; consumables, including DNA, RNA, and protein cartridges, as well as quantification kits; premix and polymerase PCR reagents; and veterinary, human, and food related testing kits. BiOptic Inc.was founded in 1993 and is headquartered in New Taipei City, Taiwan.
www.bioptic.com.twRecent News: 6850.TWO
View MorePerformance Overview: 6850.TWO
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 6850.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6850.TWO
View MoreValuation Measures
Market Cap
1.41B
Enterprise Value
1.40B
Trailing P/E
62.67
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.03
Price/Book (mrq)
3.14
Enterprise Value/Revenue
6.92
Enterprise Value/EBITDA
30.07
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
0.75
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--